-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
April 01, 2013 - 1
Comparative Effectiveness Review
Number 89
Child Exposure to Trauma: Comparative
Effectiveness of Interventions Addressing
Maltreatment
Executive Summary
Background
Condition and Therapeutic
Strategies
Child maltreatment is a global public
health problem.1, 2 In the United States
alone, approximately 6.2…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 112
Local Nonsurgical Therapies for Stage I
and Symptomatic Obstructive
Non–Small-Cell Lung Cancer
Executive Summary
Background
Non–small-cell lung cancer (NSCLC)
refers to any type of epithelial lung
cancer other than small-cell lung cancer.1
The disease arises f…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
November 01, 2012 - injection
drug users.16-22 About 60 percent of new infections occur
in individuals who report injecting drugs … partners, unprotected sex, and/or sex with a person
infected with HCV infection or using injection drugs … Recommendations for
Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women
for Maternal Health
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … It
differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - If inflammation is part
of the disease process, anti-inflammatory drugs may be
effective. … Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose … Antidementia
Treatments
• Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living;
MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - If inflammation is part
of the disease process, anti-inflammatory drugs may be
effective. … Nonsteroidal
Anti-
Inflammatory
Drugs (NSAIDs)
• No evidence was available for the effect of low-dose … Antidementia
Treatments
• Low-strength evidence shows AChEI antidementia drugs did not reduce the incidence … instrumental activities of daily living;
MCI=mild cognitive impairment; NSAIDs=nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
November 14, 2017 - It is important that this list
should not be interpreted as an endorsement of any of
these drugs so … this point should be made the first time
these drugs are mentioned. … The
authors make it clear later in this report that the safety of
the majority of these drugs has not … In both
COPES and CODIACS, the study psychiatrist prescribed
the drugs if the patient preferred an
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - considerations for AECOPD include short-
acting/long-acting inhaled bronchodilators, anti-inflammatory drugs … in patients with advanced
COPD suffering from an episode of AECOPD is unclear, especially as these drugs … mechanical ventilations
• Complementary and
alternative medicine
interventions
• Investigational drugs … and
drugs that are only available
outside of the U.S
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - $3,355
per employee during a 3-year observation
period—approximately 65 percent related
to prescription drugs … .1 At the same time, it
is well recognized that some drugs used to
treat GERD (such as proton pump
inhibitors … Among them are the publication
of approximately 3,000 new studies; the introduction of
novel drugs; the … The large disease burden,
economic impact, and market potential for new drugs
and devices explain the
-
effectivehealthcare.ahrq.gov/health-topics/hivaids
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
June 01, 2012 - Prognostic Tests
Systematic Review of Prognostic Tests
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Systematic Review of Prognostic Tests
This slide set is based on chapter 12 in a methods guide titled Methods Guide for Me…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
November 01, 2019 - Methods Research Report: Performance and Usability of Machine Learning for Screening in Systematic Reviews
Methods Research Report
Performance and Usability of Machine Learning for
Screening in Systematic Reviews: A Comparative
Evaluation of Three Tools
Methods Research Report
Performance and Usability of Ma…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2320
Published Online: October 12, 2016
Evidence Report/Technology Assessment Disposition of Comments Report
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
June 01, 2012 - Prognostic Tests
Systematic Review of Prognostic Tests
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Systematic Review of Prognostic Tests
This slide set is based on chapter 12 in a methods guide titled Methods Guide for Me…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
August 01, 2012 - Self-Measured Blood Pressure: Future Research Needs
Future Research Needs Paper
Number 16
Self-Measured Blood
Pressure:
Future Research Needs
Future Research Needs Paper
Number 16
Self-Measured Blood Pressure:
Future Research Needs
Identification of Future Research Needs From Comparative Effecti…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_technical-brief.pdf
January 01, 2012 - Wheeled Mobility (Wheelchair) Service Delivery
Wheeled Mobility
(Wheelchair) Service
Delivery
Technical Brief
Number 9
Technical Brief
Number 9
Wheeled Mobility (Wheelchair) Service Delivery
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services…
-
effectivehealthcare.ahrq.gov/health-topics/period-pain